Atezolizumab

It’s administered into the veins as an injection which needs to be supervised by a doctor. It’s the doctor who decides the necessary dosage and the frequency at which it can be used. This is decided by what the treatment is being carried out for and it may change from occasionally. It’s absolutely vital that the dosage prescribed by the doctor is strictly adhered to. Too much use can cause serious side effects. The use of the drug may show improvement only after several weeks but one needs to persist with it.

 

The Side Effects of Tecentriq Solution for Infusion

 

While most side effects are gone as the patient’s body adjusts to the medicine and requires no medical attention, a doctor must be consulted if they continue to remain. The most common side effects of Tecentriq are-

  • Constipation
  • Decreased appetite
  • Fatigue
  • Cough
  • Nausea
  • Breathlessness

Tecentriq should always be administered by a doctor or a nurse and should never be self-administered.

 

How does it Work?

 

A type of monoclonal antibody, Tecentriq 1200 mg injection takes effect by preventing a protein located on the T-cells which is a type of white blood cells from its activity. The function of these T-cells is to regulate the activity of the immune system. The Tecentriq 1200 mg injection restores the T-cells’ power to kill which stimulates the immune system to destroy cancer cells after locating them.

Please remember to take at least two to three fluid quarts every 24 hours if not instructed otherwise for self-care.

Category:

Description

This drug is more popular as Tecentriq and Atezolizumab is its generic name. The drug is used to treat non-small cell lung cancer as well as metastatic breast cancer and it belongs to monoclonal antibodies.

Manufacturer Roche Products India Pvt Ltd
Category Antineoplastic agent
Generic Name Atezolizumab
Brand Name Tecentriq
Salt Composition N/A
Chemical name Atezolizumab
Storage 2°C to 8°C
Available 1200 mg

Reviews

There are no reviews yet.

Be the first to review “Atezolizumab”

Your email address will not be published. Required fields are marked *